Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Subarachnoid Hemorrhage | 5 | 2020 | 73 | 2.260 |
Why?
|
| Brain Ischemia | 5 | 2022 | 251 | 1.210 |
Why?
|
| Vasospasm, Intracranial | 2 | 2020 | 18 | 1.180 |
Why?
|
| Cerebral Hemorrhage | 2 | 2020 | 142 | 1.050 |
Why?
|
| Stroke | 6 | 2022 | 958 | 0.980 |
Why?
|
| Neurophysiological Monitoring | 3 | 2020 | 38 | 0.900 |
Why?
|
| Intensive Care Units | 5 | 2022 | 481 | 0.860 |
Why?
|
| Hematoma, Subdural | 1 | 2020 | 20 | 0.690 |
Why?
|
| Vasoconstriction | 1 | 2020 | 104 | 0.670 |
Why?
|
| Hyponatremia | 1 | 2020 | 70 | 0.640 |
Why?
|
| Hospital Mortality | 2 | 2024 | 1009 | 0.630 |
Why?
|
| Sodium | 1 | 2020 | 290 | 0.630 |
Why?
|
| Disease Management | 2 | 2020 | 515 | 0.610 |
Why?
|
| Albumins | 2 | 2017 | 88 | 0.610 |
Why?
|
| Spectrum Analysis | 1 | 2018 | 59 | 0.590 |
Why?
|
| Brain Edema | 1 | 2018 | 67 | 0.580 |
Why?
|
| Neuroprotective Agents | 3 | 2015 | 146 | 0.570 |
Why?
|
| Critical Care | 6 | 2022 | 645 | 0.500 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2020 | 367 | 0.480 |
Why?
|
| Ischemic Attack, Transient | 1 | 2014 | 51 | 0.460 |
Why?
|
| Moyamoya Disease | 1 | 2014 | 39 | 0.450 |
Why?
|
| Magnesium Sulfate | 1 | 2012 | 51 | 0.390 |
Why?
|
| Coma | 2 | 2022 | 52 | 0.390 |
Why?
|
| Brain Death | 1 | 2011 | 53 | 0.370 |
Why?
|
| Renal Dialysis | 1 | 2018 | 842 | 0.370 |
Why?
|
| Kidney Failure, Chronic | 1 | 2018 | 866 | 0.350 |
Why?
|
| Central Nervous System Diseases | 2 | 2020 | 105 | 0.300 |
Why?
|
| Intracranial Pressure | 3 | 2019 | 176 | 0.300 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 2 | 2015 | 109 | 0.240 |
Why?
|
| Middle Aged | 11 | 2024 | 25966 | 0.240 |
Why?
|
| Pseudotumor Cerebri | 2 | 2016 | 58 | 0.230 |
Why?
|
| Adult | 11 | 2024 | 29032 | 0.220 |
Why?
|
| Academic Medical Centers | 3 | 2020 | 298 | 0.220 |
Why?
|
| Oceania | 2 | 2020 | 4 | 0.220 |
Why?
|
| Middle East | 2 | 2020 | 34 | 0.220 |
Why?
|
| Glasgow Coma Scale | 2 | 2022 | 199 | 0.210 |
Why?
|
| Neurology | 3 | 2020 | 108 | 0.210 |
Why?
|
| Latin America | 2 | 2020 | 89 | 0.210 |
Why?
|
| Asia | 2 | 2020 | 107 | 0.210 |
Why?
|
| Intracranial Aneurysm | 2 | 2013 | 93 | 0.210 |
Why?
|
| North America | 2 | 2020 | 234 | 0.200 |
Why?
|
| Status Epilepticus | 1 | 2024 | 139 | 0.200 |
Why?
|
| Internationality | 2 | 2020 | 130 | 0.200 |
Why?
|
| Humans | 27 | 2024 | 123152 | 0.200 |
Why?
|
| Neurosurgery | 2 | 2020 | 75 | 0.200 |
Why?
|
| Europe | 2 | 2020 | 375 | 0.200 |
Why?
|
| Consciousness | 1 | 2022 | 49 | 0.200 |
Why?
|
| Aged | 7 | 2024 | 19069 | 0.200 |
Why?
|
| Risk Factors | 3 | 2020 | 10010 | 0.190 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2021 | 9 | 0.190 |
Why?
|
| Aftercare | 1 | 2022 | 145 | 0.180 |
Why?
|
| Patient Comfort | 1 | 2020 | 4 | 0.170 |
Why?
|
| Hospitals, Private | 1 | 2020 | 18 | 0.170 |
Why?
|
| Reflex, Pupillary | 1 | 2020 | 15 | 0.170 |
Why?
|
| Male | 12 | 2024 | 60038 | 0.170 |
Why?
|
| Hospitals, Public | 1 | 2020 | 38 | 0.170 |
Why?
|
| Hemodynamic Monitoring | 1 | 2020 | 12 | 0.170 |
Why?
|
| Resource Allocation | 1 | 2020 | 52 | 0.170 |
Why?
|
| Resuscitation Orders | 1 | 2020 | 32 | 0.170 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 418 | 0.170 |
Why?
|
| Female | 13 | 2024 | 65442 | 0.170 |
Why?
|
| Head-Down Tilt | 2 | 2017 | 23 | 0.170 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2017 | 710 | 0.170 |
Why?
|
| Patient Transfer | 1 | 2020 | 102 | 0.160 |
Why?
|
| Texas | 2 | 2020 | 3547 | 0.160 |
Why?
|
| Health Resources | 1 | 2020 | 116 | 0.160 |
Why?
|
| Patient Admission | 1 | 2020 | 184 | 0.160 |
Why?
|
| Proof of Concept Study | 1 | 2018 | 29 | 0.150 |
Why?
|
| Osmolar Concentration | 1 | 2018 | 172 | 0.150 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2018 | 111 | 0.150 |
Why?
|
| Thrombolytic Therapy | 1 | 2018 | 203 | 0.140 |
Why?
|
| Rest | 1 | 2017 | 60 | 0.140 |
Why?
|
| Hospitalization | 3 | 2024 | 1733 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2015 | 2043 | 0.140 |
Why?
|
| Odds Ratio | 1 | 2020 | 1243 | 0.130 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 1416 | 0.130 |
Why?
|
| Referral and Consultation | 1 | 2020 | 527 | 0.130 |
Why?
|
| Palliative Care | 1 | 2020 | 428 | 0.130 |
Why?
|
| Carbon Dioxide | 1 | 2017 | 273 | 0.130 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2017 | 224 | 0.130 |
Why?
|
| Optic Disk | 1 | 2016 | 44 | 0.130 |
Why?
|
| Heart Arrest | 1 | 2020 | 341 | 0.130 |
Why?
|
| Health Personnel | 1 | 2020 | 500 | 0.120 |
Why?
|
| Logistic Models | 1 | 2020 | 1796 | 0.120 |
Why?
|
| Intracranial Hypertension | 1 | 2015 | 116 | 0.120 |
Why?
|
| Pandemics | 1 | 2022 | 1105 | 0.120 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 2836 | 0.110 |
Why?
|
| Myocardial Stunning | 1 | 2014 | 21 | 0.110 |
Why?
|
| Length of Stay | 1 | 2020 | 1285 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2020 | 519 | 0.110 |
Why?
|
| Cerebral Angiography | 1 | 2014 | 101 | 0.110 |
Why?
|
| Hospitals, Urban | 1 | 2014 | 97 | 0.110 |
Why?
|
| Therapeutic Occlusion | 1 | 2013 | 2 | 0.110 |
Why?
|
| Olfaction Disorders | 1 | 2014 | 29 | 0.110 |
Why?
|
| Serum Albumin | 1 | 2014 | 108 | 0.110 |
Why?
|
| Headache | 1 | 2014 | 107 | 0.110 |
Why?
|
| Retrospective Studies | 3 | 2020 | 15998 | 0.110 |
Why?
|
| Brain Injuries | 1 | 2019 | 734 | 0.110 |
Why?
|
| Brain | 2 | 2017 | 2946 | 0.100 |
Why?
|
| Incidence | 1 | 2020 | 3049 | 0.100 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 1073 | 0.100 |
Why?
|
| Nervous System Diseases | 1 | 2015 | 369 | 0.100 |
Why?
|
| Kidney Transplantation | 1 | 2017 | 628 | 0.100 |
Why?
|
| Neurologic Examination | 1 | 2011 | 192 | 0.090 |
Why?
|
| Embolization, Therapeutic | 1 | 2013 | 226 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1682 | 0.090 |
Why?
|
| Tomography, Optical Coherence | 1 | 2016 | 515 | 0.090 |
Why?
|
| Biomarkers | 1 | 2020 | 2942 | 0.090 |
Why?
|
| Brain Neoplasms | 1 | 2020 | 1217 | 0.090 |
Why?
|
| Prognosis | 1 | 2020 | 4505 | 0.090 |
Why?
|
| Young Adult | 4 | 2024 | 8865 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2015 | 1387 | 0.090 |
Why?
|
| Time Factors | 1 | 2020 | 6204 | 0.080 |
Why?
|
| Cause of Death | 1 | 2011 | 459 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 1 | 2011 | 501 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2011 | 375 | 0.080 |
Why?
|
| Informed Consent | 1 | 2011 | 342 | 0.080 |
Why?
|
| Tissue and Organ Procurement | 1 | 2011 | 218 | 0.080 |
Why?
|
| Stents | 1 | 2013 | 867 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 3526 | 0.070 |
Why?
|
| Electroencephalography | 2 | 2024 | 862 | 0.070 |
Why?
|
| Clinical Protocols | 2 | 2020 | 236 | 0.070 |
Why?
|
| Delivery of Health Care | 2 | 2022 | 606 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2018 | 12116 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 2848 | 0.060 |
Why?
|
| Adolescent | 3 | 2024 | 19095 | 0.060 |
Why?
|
| Morbidity | 1 | 2024 | 240 | 0.050 |
Why?
|
| Consciousness Disorders | 1 | 2022 | 23 | 0.050 |
Why?
|
| Checklist | 1 | 2022 | 86 | 0.050 |
Why?
|
| Surveys and Questionnaires | 2 | 2022 | 3660 | 0.050 |
Why?
|
| United States | 3 | 2024 | 10629 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2022 | 132 | 0.050 |
Why?
|
| Tracheostomy | 1 | 2024 | 191 | 0.050 |
Why?
|
| Herpesvirus 2, Human | 1 | 2021 | 13 | 0.050 |
Why?
|
| Acyclovir | 1 | 2021 | 45 | 0.050 |
Why?
|
| Simplexvirus | 1 | 2021 | 99 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 3379 | 0.040 |
Why?
|
| Personnel Management | 1 | 2020 | 7 | 0.040 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2020 | 19 | 0.040 |
Why?
|
| Respiratory Therapy | 1 | 2020 | 21 | 0.040 |
Why?
|
| Transportation of Patients | 1 | 2020 | 55 | 0.040 |
Why?
|
| Pharmacists | 1 | 2020 | 83 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2022 | 488 | 0.040 |
Why?
|
| Prevalence | 1 | 2024 | 2405 | 0.040 |
Why?
|
| Bed Rest | 1 | 2017 | 15 | 0.040 |
Why?
|
| Weightlessness Simulation | 1 | 2017 | 17 | 0.040 |
Why?
|
| Hospital Bed Capacity | 1 | 2017 | 24 | 0.040 |
Why?
|
| Cerebral Veins | 1 | 2017 | 16 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2022 | 623 | 0.030 |
Why?
|
| Recurrence | 1 | 2021 | 1422 | 0.030 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 271 | 0.030 |
Why?
|
| Weightlessness | 1 | 2017 | 43 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2020 | 679 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 312 | 0.030 |
Why?
|
| Spinal Puncture | 1 | 2015 | 53 | 0.030 |
Why?
|
| Space Flight | 1 | 2017 | 114 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2016 | 6028 | 0.030 |
Why?
|
| Intraocular Pressure | 1 | 2015 | 144 | 0.030 |
Why?
|
| Surgical Procedures, Operative | 1 | 2017 | 182 | 0.030 |
Why?
|
| Serum Albumin, Human | 1 | 2014 | 10 | 0.030 |
Why?
|
| Sensory Thresholds | 1 | 2014 | 34 | 0.030 |
Why?
|
| ROC Curve | 1 | 2015 | 557 | 0.030 |
Why?
|
| Telemedicine | 1 | 2020 | 426 | 0.030 |
Why?
|
| Physicians | 1 | 2020 | 584 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 6373 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2017 | 1588 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2014 | 284 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 1259 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1873 | 0.020 |
Why?
|
| Comorbidity | 1 | 2017 | 1497 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2020 | 1158 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2021 | 8103 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 4704 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 3251 | 0.020 |
Why?
|
| Endovascular Procedures | 1 | 2013 | 724 | 0.020 |
Why?
|
| Animals | 1 | 2014 | 33720 | 0.010 |
Why?
|
VENKATASUBBA RAO's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(176)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(13)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_